Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 (hnRNP A2/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells

Cell Biochemistry and Function

Volumn 27, Issue 4, 2009, Pages 228-237

  Ma, Kit Wan ^a   Au, Shannon W N ^a   Waye, Mary M Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Heterogeneous nuclear ribonucleoprotein A2 B1 isoform B1 (hnRNP A2 B1 isoform B1); Liver; SUMO; Sumoylation; Uracil DNAglycosylase (UDG)

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT 1; PROTEIN INHIBITOR OF ACTIVATED STAT 3; PROTEIN INHIBITOR OF ACTIVATED STAT ALPHA; PROTEIN INHIBITOR OF ACTIVATED STAT BETA; PROTEIN INHIBITOR OF ACTIVATED STAT GAMMA; SUMO 1 PROTEIN; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE;

ARTICLE; CANCER CELL; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; DATABASES, GENETIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LUNG NEOPLASMS; PROTEIN ISOFORMS; SUMO-1 PROTEIN; TISSUE DISTRIBUTION; UP-REGULATION; URACIL-DNA GLYCOSIDASE;

EID: 68249138164     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1562     Document Type: Article

References (61)

1. Janka C, Selmi C, Gershwin ME, Will H, Sternsdorf T. Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis. Hepatology 2005; 41: 609-616.
2. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 2005; 25: 1879-1890.
3. Ohshima T, Koga H, Shimotohno K. Transcriptional activity of persoxisome proliferators-activated receptor gamma is modulated by SUMO-1 modification. J Biol Chem 2003; 279: 29551-29557.
4. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997; 3: 2237-2246.
5. Moon YW, Park WS, Vortmeyer AO, et al. Mutation of the uracil DNA glycosylase gene detected in glioblastoma. Mutat Res 1998; 421: 191-196.
6. Fielding P, Turnbull L, Prime W, Walshaw M, Field JK. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 1999; 5: 4048-4052.
7. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 1999; 59: 1404-1407.
8. Radany EH, Dornfeld KJ, Sanderson RJ, et al. Increased spontaneous mutation frequency in human cells expressing the phage PBS2-encoded inhibitor of uracil-DNA glycosylase. Mutat Res 2000; 461: 41-48.
9. Zhou J, Allred DC, Avis I, et al. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonulceoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001; 66: 217-224.
10. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002; 183: 215-220.
11. Wu S, Sato M, Endo C, et al. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003; 41: 179-186.
12. Fan J, Wilson DM 3rd Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radic Biol Med 2005; 38: 1121-1138.
13. Endter C, Kzhyshkowska J, Stauber R, Dobner T. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci USA 2001; 98: 11312-11317.
14. Joseph J, Tan SH, Karpova TS, McNally JG, Dasso M. SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles. J Cell Biol 2002; 156: 595-602.
15. Kotaja N, Karvonen U, Janne OA, Palvimo JJ. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 2002; 22: 5222-5234.
16. Moilanen AM, Karvonen U, Poukka H, Yan W, et al. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem 1999; 274: 3700-3704.
17. Sharma M, Li X, Wang Y, et al. hZimp10 is an androgen receptor coactivator and forms a complex with SUMO-1 at replication foci. EMBO J 2003; 22: 6101-6114.
18. Yan W, Santti H, Janne OA, Palvimo JJ, Toppari J. Expression of the E3 SUMO-1 ligases PIASx and PIAS1 during spermatogenesis in the rat. Gene Exp Pat 2003; 3: 301-308.
19. Vigodner M, Morris PL. Testicular expression of small ubiquitin-related modifier-1 (SUMO-1) supports multiple roles in spermatogenesis: Silencing of sex chromosomes in spermatocytes, spermatid microtubule nucleation, and nuclear reshaping. Dev Biol 2005; 282: 480-492.
20. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 1990; 4: 1541-1551.
21. Chakrabarti SR, Sood R, Nandi S, Nucifora G. Posttranslational modification of TEL and TEL/AML by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc Natl Acad Sci USA 2000; 97: 13281-13285.
22. Giorgino F, de Robertis O, Laviola L, et al. The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc Natl Acad Sci USA 2000; 97: 1125-1130.
23. Kim J, Cantwell CA, Johnson PF, Pfarr CM, Williams SC. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J Biol Chem 2002; 277: 38037-38044.
24. Lalioti VS, Vergarajauregui S, Pulido D, Sandoval IV. The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1. J Biol Chem 2002; 277: 19783-19791.
25. Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 2004; 279: 27233-27238.
26. Trajkovski M, Mziaut H, Altkruger A, et al. Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in β-cells. J Cell Biol 2004; 167: 1063-1074.
27. Wang L, Banerjee S. Differential PIAS3 expression in human malignancy. Oncol Rep 2004; 11: 1319-1324.
28. Kozu T, Henrich B, Schafer KP. Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1. Genomics 1995; 25: 365-371.
29. Burd CG, Swanson MS, Gorlach M, Dreyfuss G. Primary structures of the heterogeneous nuclear ribonuceloprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts. Proc Natl Acad Sci USA 1989; 86: 9788-9792.
30. Lyst MJ, Stancheva I. A role for SUMO modification in transcriptional repression and activation. Biochem Soc Trans 2007; 35: 1389-1392.
31. Desterro JM, Rodriguez MS, Hay RT. Regulation of transcription factors by protein degradation. Cell Mol Life Sci 2000; 57: 1207-1219.
32. Stelter P, Ulrich HD. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003; 425: 188-191.
33. Fischer JA, Muller-Weeks S, Caradonna S. Proteolytic degradation of the nuclear isoform of uracil-DNA glycosylase occurs during the S phase of the cell cycle. DNA Repair 2004; 3: 505-513.
34. Pioli PA, Rigby WF. The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. J Biol Chem 2001; 276: 40346-40352.
35. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8: 947-956.
36. Bessman MJ, Lehman IR, Adler J, Zimmerman SB, Simms ES, Kornberg A. Enzymatic synthesis of deoxyribonucleic acid III. The incorporation of pyrimidine and purine analogues into deoxyribonucleic acid. Proc Natl Acad Sci USA 1958; 44: 633-640.
37. Shapiro R, Klein RS. The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry 1966; 5: 2358-2362.
38. Hayatsu H. Co-operative mutagenic actions of bisulfite and nitrogen nucleophiles. J Mol Biol 1977; 115: 19-31.
39. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer J, deRiel JK, Sirover MA. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehydes-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 1991; 88: 8460-8464.
40. Ovadi J, Telegdi M, Batke J, Keleti T. Functional non-identity of subunits and isolation of active dimers of D-glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 1971; 22: 430-438.
41. Hardeland U, Steinacher R, Jiricny J, Schar P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J 2002; 21: 1456-1464.
42. Steinacher R, Schar P. Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Curr Biol 2005; 15: 616-623.
43. Choi YD, Dreyfuss G. Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): a unique supramolecular assembly. Proc. Natl. Acad. Sci. USA 1984; 81: 7471-7475.
44. Pinol-Roma S, Choi YD, Matunis MJ, Dreyfuss G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev 1988; 2: 215-227.
45. Economidis IV, Pederson T. Assembly of nuclear ribonucleoprotein particles during in vitro transcription. Proc Natl Acad Sci USA 1982; 79: 1469-1473.
46. Dreyfuss G. Structure and function of nuclear and cytoplasmic ribonucleoprotein particles. Annu Rev Cell Biol 1986; 2: 459-498.
47. Kiledjian M, DeMaria CT, Brewer G, Novick K. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol Cell Biol 1997; 17: 4870-4876.
48. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 1997; 89: 597-606.
49. Mili S, Shu HJ, Zhao Y, Pinol-Roma S. Distinct RNP complexes of shuttling hnRNP proteins with pre-mRNA and mRNA: candidate intermediates in formation and export of mRNA. Mol Cell Biol 2001; 21: 7307-7319.
50. Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994; 13: 5483-5495.
51. Vassileva MT, Matunis MJ. SUMO modification of heterogeneous nuclear ribonucleoproteins. Mol Cell Biol 2004; 24: 3623-3632.
52. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J Biol Chem 2001; 276: 18513-18518.
53. Hong Y, Rogers R, Matunis MJ, et al. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem 2002; 276: 40263-40267.
54. Ungureanu D, Vanhatupa S, Gronholm J, Palvimo JJ, Silvennoinen O. SUMO-1 conjugation selectively modulates STAT1-mediated gene responses. Blood 2005; 106: 224-226.
55. Song J, Durrin LK,Wilkinson TA, Krontiris TG, Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci USA 2004; 101: 14373-14378.
56. Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002; 3: 195-205.
57. Li T, Evdokimov E, Shen RF, Chao CC, et al. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc Natl Acad Sci USA 2004; 101: 8551-8556.
58. Mao Y, Sun M, Desai SD, Liu LF. SUMO-1 conjugation to topoisomerase I possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci USA 2000; 97: 4046-4051.
59. Bachant J, Alcasabas A, Blat Y, Kleckner N, Elledge SJ. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol Cell 2002; 9: 1169-1182.
60. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002; 419: 135-141.
61. Kawabe Y, Seki M, Seki T, et al. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1. J Biol Chem 2000; 275: 20963-20966.